REG - Molecular Energies - Director Share Purchase

Molecular EnergiesAnnouncement

02/04/2024 15:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240402:nRSB0141Ja&default-theme=true

RNS Number : 0141J  Molecular Energies PLC  02 April 2024

2 April 2024

 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE MARKET
ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY
VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED) ("MAR"). UPON
THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE,
THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

MOLECULAR ENERGIES PLC

("Molecular" or the "Company")

 

Director Share Purchase

 

Molecular Energies plc (AIM: MEN), the international energy company,
announces it has today been informed that on 2 April 2024, PLLG Investments
Limited, a company wholly beneficially owned by Peter Levine, Chairman and
largest shareholder in the Company, acquired 262,000 ordinary shares in the
capital of the Company ("Ordinary Shares") at a price of 7p per Ordinary Share
(the "Share Purchase"). This reflects the statement made by Peter Levine in
the Company's announcement of 28 March 2024 (the "Announcement") that he has
"conviction in the value of Molecular as a whole" as a private enterprise and
notwithstanding the proposed cancellation of the admission of the Ordinary
Shares to trading on the AIM Market of the London Stock Exchange. Peter Levine
reiterates the statement made in the Announcement that he "invite s  any
shareholders so minded to continue the journey alongside" but that "whilst
making no commitment to do so, I do not rule out in the fullness of time and
subject to de-listing and on becoming a private company making proposals to
buy the shares of certain of those holders who either do not wish or are
unable to be invested in a private business". Peter Levine is currently
restricted from acquiring further Ordinary Shares without making a
logistically burdensome general offer to all other shareholders since the
Takeover Code continues to apply to the Company.

Following the Share Purchase, Peter Levine has a beneficial interest in
3,269,267 Ordinary Shares representing 26.41 per cent. of the issued share
capital. Peter Levine and those acting in concert with him have combined
beneficial interest in 3,705,981 Ordinary Shares representing 29.94 per cent.
of the issued share capital.

 

 Molecular Energies PLC                                              +44 (0)20 7016 7950

 Peter Levine, Chairman                                              info@molecularenergiesplc.com (mailto:info@molecularenergiesplc.com)

 Rob Shepherd, Group FD
 Cavendish Capital Markets Limited (Nominated Adviser & Broker)      +44 (0)20 7220 0500

 Simon Hicks

 George Dollemore
 Tavistock (Financial PR & IR)                                       +44 (0)20 7920 3150

 Simon Hudson, Nick Elwes, Saskia Sizen

 

 

For the purposes of MAR, Article 2 of Commission Implementing Regulation (EU)
2016/1055 and the UK version of such implementing regulation (as
amended), the person responsible for arranging for the release of this
Announcement on behalf of the Company is Peter Levine, Chairman.

 

Pursuant to the notification obligations in accordance with Article 19 of the
Market Abuse Regulation (MAR)

 1.  Details of PDMR / person closely associated with them ('PCA')
 a)  Name                                     Peter Levine through PLLG Investments Limited
 2.  Details of PDMR / person closely associated with them ('PCA')
 a)  Position / status                        Chairman
 b)  Initial notification / amendment         Initial notification
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                     Molecular Energies plc
 b)  LEI                                      213800MA2ZN22I4ITA79
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument;

(ii) each type of transaction; (iii) each date; and (iv) each place where
     transactions have been conducted
 c)  Description of the financial instrument  Ordinary shares of 1p each

                                              ISIN: GB00B3DDP128
 d)  Nature of the transaction                Purchase of Ordinary Shares
 e)  Price and volume                         Price (PENCE)  Volume
                                              Peter Levine  7p             262,000

 f)  Aggregated information

      Aggregated volume                        262,000 Ordinary Shares at 7p per Ordinary Share

      Price
 g)  Date of the transaction                  2 April 2024
 h)  Place of the transaction                 London Stock Exchange, AIM (XLON)

f)

Aggregated information

 

 Aggregated volume

 

 Price

 

 

 262,000 Ordinary Shares at 7p per Ordinary Share

 

g)

Date of the transaction

2 April 2024

h)

Place of the transaction

London Stock Exchange, AIM (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUURSRSRUSRAR